Neurocrine Biosciences, Inc.
corporate_fare Company Profile
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for NBIX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Neurocrine Biosciences Reports Strong 2025 Sales, Faces DOJ Probe & Patent Suit Amidst Mixed Pipeline Results
- Neurocrine Biosciences Reports Strong Q4 & FY25 Results, Provides Solid 2026 Guidance, and Advances Pipeline
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$2.86B
Net Income
$478.6M
Diluted EPS
$4.67
Op. Cash Flow
$782.7M
Free Cash Flow
$748.7M
Gross Profit
$2.81B
Operating Income
$619.1M
Cash & Equivalents
$713M
Debt / Equity
0.00×
Net Margin
16.7%
Shares Outstanding
100.1M sh
Source: 10-K · filed 2026-02-11 · accession 0000914475-26-000007
show_chartPrice Chart
Loading chart...